Non interventional study
Non interventional study is an intervention with 51 clinical trials. Currently 7 active trials ongoing. Historical success rate of 97.1%.
Success Metrics
Based on 34 completed trials
Phase Distribution
No phase data available
Trial Status & Enrollment
97.1%
34 of 35 finished
2.9%
1 ended early
7
trials recruiting
51
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Status
Recent Activity
REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
Dosage and PD Study of Eftrenonacog-alfa
National Acalabrutinib Observational Study
Behavioral Assessment Method Index
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
Clinical Trials (51)
REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
Dosage and PD Study of Eftrenonacog-alfa
National Acalabrutinib Observational Study
Behavioral Assessment Method Index
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
Middle East Coronary Artery Ectasia Registry
Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC
Survey on NIV Settings in the Intensive Care Unit for Acute Exacerbation of COPD
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
" Sweeper " and Epiretinal Membrane Surgery
Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis
Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study
Pediatric Pertussis in Ambulatory Settings
Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein
Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding
Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis
Head and Neck cancERs International cOviD-19 collabOraTion
Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease
ICU Readmission in Adult Egyptian Patients Undergoing Living Donor Liver Transplant
Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 51